Herbal Medicines, etc. in the product categories of Non-Sterile, Sterile, Nutraceuticals, Otc + Lifestyle, and it exports its products mainly to Ethiopia and other parts of the world.Product Portfolio: The four important product categories include: Non-Sterile: This comprises Capsules, Tablets, Dry syrup, etc. in Antibiotics/Anti-bacterial, Anti-fungal, Gastro-Intestinal Drugs, etc. Sterile:...
Coral Laboratories' Registrar and Share Transfer Agent (RTA) has confirmed the accurate processing of dematerialised securities for the quarter ended June 30, 2025. This means all physical shares submitted for conversion to electronic form were properly accepted or rejected and then reported to the depositories. The corresponding physical certificates were...
Coral Laboratories has announced a notice to shareholders regarding the transfer of equity shares to the Investor Education and Protection Fund (IEPF). This step involves transferring shares of shareholders who have not claimed dividends or engaged with the company for a specified period. The move ensures regulatory compliance and protects...
Coral Laboratories Limited has announced its Annual Secretarial Compliance Report for the financial year ended March 31, 2025. The report confirms overall compliance with applicable SEBI regulations and company secretarial standards, with two minor procedural delays: a late submission of the Limited Review Report for the half-year financial results and...
